云南白药：通过“内涵式”和“外延式”协同发展，推动公司产业组合不断优化是公司主要的增长模式

Core Viewpoint - Yunnan Baiyao (000538) emphasizes its growth model through "internal" and "external" collaborative development to continuously optimize its industry portfolio [1] Group 1: Internal Development - The "internal" development focuses on enhancing efficiency and stabilizing the basic operations, concentrating on the pharmaceutical, health, and distribution sectors [1] - The approach aims for overall maximization of benefits by systematically improving the entire industry chain, value chain, and production factors [1] - The company is committed to promoting high-quality development of its main business through these internal strategies [1] Group 2: External Development - The "external" development emphasizes foresight and strategic alignment, actively exploring strategic mergers and acquisitions, as well as partnerships [1] - This strategy aims to complement and strengthen existing industry segments, enabling rapid breakthroughs in current growth bottlenecks [1] - The goal is to build a healthy and sustainable industry portfolio system, achieving high-quality sustainable development [1]